- £349.21m
- £412.54m
- £178.84m
- 84
- 50
- 92
- 92
Annual balance sheet for Alliance Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 28.9 | 29.1 | 31.7 | 22.4 | 32.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 24.2 | 27.7 | 48.2 | 51.7 | 46.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 77.2 | 81 | 105 | 104 | 104 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 15.9 | 4.83 | 5.58 | 5.72 | 5.44 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 509 | 503 | 509 | 415 | 369 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 30.2 | 40.6 | 47 | 40.6 | 36.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 228 | 221 | 244 | 197 | 161 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 281 | 282 | 266 | 218 | 208 |
Total Liabilities & Shareholders' Equity | 509 | 503 | 509 | 415 | 369 |
Total Common Shares Outstanding |